Wayfinding: RFID 0. Telemedical Retinal Imaging of : Diabetic Retinopathy, Glaucoma, Macular Degeneration 1.

Slides:



Advertisements
Similar presentations
Discovery: Stem Cell Biology NIH Actions Continue infrastructure award program Characterize cell lines Stimulate more research on basic biology Train.
Advertisements

By: Matt Varga Gene Therapy. Background There have been many major breakthroughs in the field of medicine over the last several decades. Research and.
Anna Williams Scottish Senior Research Fellow and Honorary Consultant Neurologist MS and Update on research.
How might we cure diseases in the future?. Using what we know about genes Pharmacogenetics/ Pharmacogenomics Gene Therapy Regenerative medicine.
Retreat Topics iPSC Opportunities in NIAMS Diseases Science Management Forum: Leveraging and Strategic Funding Collaborations Atopic Dermatitis Advancing.
Louis Carney III BME 281 October 8 th,  About 300,000 Americans a year suffer damage to peripheral and central nerves.  Nerves damaged in the.
By Anthony Catalano. The Extracellular Matrix (ECM) Provides support to tissue Composed of fibers: Collagen and Elastin Made up of cells called Fibroblasts.
By Jordan Sudario-Cook. Axolotl The axolotl is a species of salamander that lives mainly in areas of Mexico. This species of salamander have extensive.
VA Rehabilitation Research: Achievements and Future Directions Meeting for VA IRB Chairpersons: August / 2012 Patricia A. Dorn, PhD, Interim Director.
Spinal Cord Injury Research at the Reeve-Irvine Research Center SOCCCD Collaborative CTE Grant Funded Externship Adam Atallah- Anatomy and Physiology.
Current and Upcoming Clinical Trials Now, let’s consider 2 treatments where few or no photoreceptor cells remain alive. Possible treatments here would.
Preston Steele BME 281.  The brains ability to actively rewire itself in response to external stimuli  Creation of BION microstimulator based on this.
Spinal Cord Injury/Repair
CSE 490i: Design in Neurobotics Yoky Matsuoka (instructor) Lecture: TTH 10:30-11:20 EEB 003 Labs: TTH 11:30-1:20 CSE 003E.
Department of Neurosciences Newcastle upon Tyne Multimodality treatment of spinal cord injury: Endogenous stem cells and other magic bullets Dr Andrea.
Stem Cells and Regenerative Medicine. “Glow-in-the-dark” dogs!
Stem Cells and Regenerative Medicine. “Glow-in-the-dark” dogs!
Faeze. Introduction  Stem cell therapy is certainly a promising area for research. These have the ability to give rise to many specialize cells in on.
Stem Cells and Regenerative Medicine
Stem Cells and Regeneration 의공학개론, Fall 2012 Anne J. Kim, Ph.D.
HISTORY OF MEDICAL BIOTECHNOLOGY CHANGES IN THE LAST 15 YEARS.
Nerve Cell Regeneration Heather Wilson and Alicia DiCola.
By Matthew Sampson. Overview What is it? Previous Treatments Monoclonal Antibodies Chimeric Molecules Oral Therapies Hematopoietic Stem Cells Future.
Stem Cells and Regenerative Medicine. “Glow-in-the-dark” dogs!
Spinal Cord Injuries.  There are an estimated 10,000 to 12,000 spinal cord injuries every year in the United States.  The cost of managing the care.
References  Lecture notes (hyperlink)  Activity notes (hyperlink)  More links… Clinical Trials.
BIOMEDICAL REPAIR.
Stem Cells General Concepts By Syed Tahir Abbas Shah.
MNA Mosby ’ s Long Term Care Assistant Chapter 46 Rehabilitation and Restorative Nursing Care.
The Immediate Challenge for NIH and Human ES Cell Research Generate and characterize distribution quality human ES cell lines from the NIH Registry Stimulate.
Worldwide, an estimated 2.5 million people live with spinal cord injury (SCI), with more than 130,000 new injuries reported each year. SCI has a significant.
Defining the right clinical problems for nanotechnology Table 2 John S. Oghalai, MD.
Biotechnology Research Project by Anna Dong, Soojin Jeong, Reina Ooka -Stem Cells-
Neuro-Prosthetic Project (Humanities) Norman, Mathew, Armando, Chris.
Copyright © 2011, 2007, 2003, 1999 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 39 Nervous System and Musculo-Skeletal Disorders.
New Hope for Hurt Neurons Is there recovery after damage to the spinal cord or brain? Can stem cells be used to reconstruct broken pathways? A few years.
High-Impact Research to Change Lives. LEARNING OBJECTIVES Participants should leave energized by progress occurring in MS research, and should be able.
HEALH CARE DELIVERY SYSTEM General Hospital l Facility where patients are hospitalized a short time (few days to a few weeks) l Provide a wide range.
Rehabilitation Research & Development Service Danielle M. Kerkovich, Ph.D. Acting Assistant Director Website:
Reviewed by: AGNES Purwidyantri D  To create products that improve tissue function or heal tissue defects.  Replace diseased or damaged tissue.
Components of IDEA Definitions
1 Safety of Cell Therapies Derived from Human Embryonic Stem Cells CTGTAC #45 April 10, 2008.
Neuromuscular Microstimulators Chris MorinoBME 281.
What is Neural Engineering Tae-Seong Kim, Ph.D.. Neural Engineering Neural engineering also known as Ne uroengineering is a discipline that uses engineering.
Stem Cells What They Are and What They Do February 22, 2008.
FDA’s Public Workshop: Innovative Systems for Delivery of Drugs and Biologics: Scientific, Clinical, and Regulatory Challenges Paul Goldfarb, MD, FACS.
The e-Dura: The New Flexible Spinal Implant That Will Revolutionize Spinal Cord Injury Treatment The Spinal Cord and Effects of Spinal Cord Injuries (SCI)
Project NEUWalk George Halkidis BME 181 Pres. #1.
Using Stem Cells to Treat Ailments of the Nervous System Crista Chavez, Jacqueline Doody, Nina Roxo, Aleksandra Sabov & Zachary Taylor Faculty Mentor:
 Mechanical Arm Brace: Loss of Neuronal Function Jake Herman.
PROSTHETIC LEG PRESENTED BY:-AWAIS IJAZ HASNAT AHMED KHAN.
Medical Aids and Devices
Scientific investigations & work from many fields to improve the health and well being of humans and animals.
Recent Studies Funded by the Progressive MS Alliance Tim Coetzee, PhD ACTRIMS 2016.
Regenerative Medicine Regenerative medicine~ Goal: to grow replacement tissue or organs for patients who have sustained an injury or have a disease that.
ETHICS IN BIOMEDICAL ENGINEERING BY RYAN IVONE. INTRODUCTION Goal : Use their knowledge, skills, and abilities to enhance the safety, health, and welfare.
Remyelination Therapy for Multiple Sclerosis By Jordan Burnett With Dr. Gullo clerosis.jpg.
Dr. Diala Abu-Hassan, DDS, PhD Central Nervous System Dr. Diala Abu-Hassan School of Medicine 1
BIO-BINGO Human Systems Unit 8A.
BIOMEDICAL ENGINEERING
Induced Pluripotent Stem Cells
Stem Cells: Scientific Potential and Alternatives
Discovery: Stem Cell Biology NIH Actions Continue infrastructure award program Characterize cell lines Stimulate more research on basic biology Train.
Department of Veterans Affairs (VA): Program in Rehabilitation Research ̶ Overview & Funding Opportunities Christopher A. Moore, Ph.D., Dean College of.
How might we cure diseases in the future?
Disability Any lost, absent or impaired physical or mental function
From Bench to Clinical Applications: Money Talks
Julius A. Steinbeck, Lorenz Studer  Neuron 
Stem cell Basics.
Web-based Binational Student Presentations
Presentation transcript:

Wayfinding: RFID 0

Telemedical Retinal Imaging of : Diabetic Retinopathy, Glaucoma, Macular Degeneration 1

Hearing and Tinnitus Developing new devices to expand diagnostic opportunities Development of Tinnitus Management Program From inception through implementation 2

3 Spinal Cord Injury Translational Collaborative Consortium for Regenerative Research Goal : Develop and translate novel therapies bench to bedside Focus: Restoration of upper limb function with 2 research teams Discover genes responsible for axon growth and inhibition of growth in the adult spinal cord Testing of combination therapies in non-human primate (NHP) models (cells, growth factors and drugs) Long-term, chronic effects cell-based therapies on functional recovery in NHP models Determining best approach overcome formation of glial scar (body’s attempt repair injured cord) Use cells and biologics already used for other clinical indications Speed up regulatory process towards “investigational new drug” indication by FDA Built-in replication criterion :Teams must reproduce results Use rodent & NHP contusion & hemisection models for scale-up, feasibility of therapy Must overcome obstacle translating animal to human

West Haven: Human Oligodendrocyte Precursor for Myelination of Axons 4 Testing safety and ability of GERON cells used in clinical trials to form myelin around injured axons after lesion in NHP spinal cord Cells are safe: survival studies up to 3 years post-transplantation with no tumor formation or adverse side effects GERON cells form myelin and are superior to “self-repair” Self – repair 1 year after lesion Geron OPC 7 wks after lesion

San Diego: Human Neural Progenitor Cells (NeuralStem™) Form Functional Axon Bridges with Host Spinal Cord Identified genetic signaling molecules involved in promoting and retarding growth of axons post-SCI Studies blocking genetic signals that retard axon growth demonstrate increase in growth post-injury in rodents. Removing inhibition results in growth Transplantation of NeuralStem™ result in clinically relevant growth – up to 20 segments in rats, equivalent to inches in humans Now being tested in NHP 5

Neural Prostheses: Functional Electrical Stimulation (FES) Don Crago, U.S. Army Veteran injured while on active duty Fort Carson, CO Result of car accident he is paralyzed from chest down uses FES system for exercise and limited walking at home 6

Traumatic Brain Injury (TBI): Intensive Multimodal Rehabilitation Advanced Rehab Devices Recreation Therapy Physical Therapy Assistive Devices 7

Rehabilitation Robotics: Physical Therapy Clinical Trial of Robot-Assisted Physical Therapy http// 8

DEKA arm: Research Plan Past and Future Congressional Hearing 2004 DARPA’s “Revolutionizing Prosthetics 2007/2009” Programs began 2005 VA Prosthetic Arm Optimization Study (3 VA, 1 DoD site) “Take-Home” Study to begin 2012 Transition to Additional Applications Collaborations with other agencies (DoD/DARPA) 9

Artificial Limbs: Ankle-Foot Prosthesis Dr. Hugh Herr Powered Electronic Ankle-Foot Prosthesis May Improve Mobility of Veteran Amputees to Walk 10

Osseointegration Biohybrid limb combining living tissue with external prosthetic device consisting of a titanium rodBiohybrid limb combining living tissue with external prosthetic device consisting of a titanium rod Device is of the leg stump fused into boneDevice is of the leg stump fused into bone Problem has been infectionProblem has been infection Salt Lake City VA made progress by using porous disc placed under the skin – animal studiesSalt Lake City VA made progress by using porous disc placed under the skin – animal studies 1-year infection free without antibiotics1-year infection free without antibiotics Recently received FDA approval for human trialRecently received FDA approval for human trial Photo from work in Europe 11

Brain-Computer Interface 12

Journal of Rehabilitation Research & Development: JRRD 13 JRRD sponsored by RR&D Scientific peer reviewed journal Fully accessible online: sign up today!

ORD/RR&D Supported Research: Available to the Public Search on NIH RePORTER website Merit, Pilot, Career Development (recent addition) Other award types to follow as forms are generated for use in eRA Search on Clinical Trials website 14

15